OK BIOTECH ApS: Financial statements 2022
CVR: 20136693
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
OK BIOTECH ApS (CVR 20136693) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,413,050 and a net result of DKK -11,413,568 compared with DKK 28,266,601 the year before. Equity in the 2022 report amounted to DKK 267,611,296. The solvency ratio was 93.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,413,050
- Profit/Loss
- DKK -11,413,568
- Equity
- DKK 267,611,296
- Total Assets
- DKK 285,340,607
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -1.4 mio. | -11.4 mio. | 267.6 mio. | 1 |
| 2021 | - | -4.1 mio. | 28.3 mio. | 291 mio. | 1 |
| 2020 | - | -2.6 mio. | 10.1 mio. | 274.8 mio. | 1 |
| 2019 | - | -2.2 mio. | 20 mio. | 264.9 mio. | 1 |
| 2018 | - | -1.5 mio. | -4.4 mio. | 256.9 mio. | - |
Official annual report
Keep an eye on OK BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
OK BIOTECH ApS has published its annual report for 2021. Gross profit came to DKK -4,095,437, and the net result was DKK 28,266,601.
About OK BIOTECH ApS
OK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Egå, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ole Kaae Hansen. The company's owners include Ole Kaae Hansen, Camilla Kaae Wedel and Helene Wedel. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -859,156 and a net result of DKK -194,439,082 compared with DKK 11,064,189 the year before. Equity in the 2025 report amounted to DKK 82,509,407.